Note 10 - Revenue From Contracts With Customers (Tables)

9 Months Ended

Jun. 30, 2024

Notes Tables

Disaggregation of Revenue [Table Text Block]

	Three months ended June 30,				Nine months ended June 30,
	2024		2023		2024		2023
Significant Business Line
Multiomics	$	63,619	$	63,846	$	188,556	$	187,172
Core Products (1)		49,440		47,810		143,170		139,386
Sample Repository Solutions		31,233		27,531		90,646		82,452
B Medical Systems		28,517		26,761		63,888		83,705
Total revenue	$	172,809	$	165,948	$	486,260	$	492,715

Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table Text Block]

	As of June 30, 2024
	Less than 1 Year		Greater than 1 Year		Total
Remaining performance obligations	$	77,637	$	18,392	$	96,029